{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:39Z","timestamp":1791928719794,"version":"4.3.4"},"reference-count":51,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"DOI":"10.1167\/iovs.18-25376","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T15:33:21Z","timestamp":1547480001000},"page":"82","source":"Crossref","is-referenced-by-count":31,"title":["Critical Role of mTORC2-Akt Signaling in TGF-\u03b21-Induced Myofibroblast Differentiation of Human Pterygium Fibroblasts"],"prefix":"10.1167","volume":"60","author":[{"given":"Sun Woong","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Yonsei University, Wonju College of Medicine, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-In","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Hallym University, Chuncheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Thapa","sequence":"additional","affiliation":[{"name":"Institute of Bioscience and Biotechnology, Hallym University, Chuncheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selikem","family":"Nuwormegbe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Yonsei University, Wonju College of Medicine, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunwook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Hallym University, Chuncheon, Korea"},{"name":"Institute of Bioscience and Biotechnology, Hallym University, Chuncheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"bib1","doi-asserted-by":"crossref","unstructured":"Kim\n              KW\n             ParkSH KimJC. Fibroblast biology in pterygia. Exp Eye Res. 2016; 142: 32\u201339.","DOI":"10.1016\/j.exer.2015.01.010"},{"key":"bib2","doi-asserted-by":"crossref","unstructured":"Chui\n              J\n             Di GirolamoN WakefieldD CoroneoMT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008; 6: 24\u201343.","DOI":"10.1016\/S1542-0124(12)70103-9"},{"key":"bib3","doi-asserted-by":"crossref","unstructured":"Saw\n              SM\n             TanD. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999; 6: 219\u2013228.","DOI":"10.1076\/opep.6.3.219.1504"},{"key":"bib4","doi-asserted-by":"crossref","unstructured":"Nuwormegbe\n              SA\n             SohnJH KimSW. A PPAR-gamma agonist rosiglitazone suppresses fibrotic response in human pterygium fibroblasts by modulating the p38 MAPK pathway. Invest Ophthalmol Vis Sci. 2017; 58: 5217\u20135226.","DOI":"10.1167\/iovs.17-22203"},{"key":"bib5","doi-asserted-by":"crossref","unstructured":"Di Girolamo\n              N\n             ChuiJ CoroneoMT WakefieldD. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004; 23: 195\u2013228.","DOI":"10.1016\/j.preteyeres.2004.02.002"},{"key":"bib6","doi-asserted-by":"crossref","unstructured":"Bradley\n              JC\n             YangW BradleyRH ReidTW SchwabIR. The science of pterygia. Br J Ophthalmol. 2010; 94: 815\u2013820.","DOI":"10.1136\/bjo.2008.151852"},{"key":"bib7","unstructured":"Kim\n              SW\n             LeeJ LeeB RhimT. Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2. Mol Vis. 2014; 20: 1192\u20131202."},{"key":"bib8","doi-asserted-by":"crossref","unstructured":"Kaufman\n              SC\n             JacobsDS LeeWB DengSX RosenblattMI ShteinRM. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013; 120: 201\u2013208.","DOI":"10.1016\/j.ophtha.2012.06.066"},{"key":"bib9","doi-asserted-by":"crossref","unstructured":"Kria\n              L\n             OhiraA AmemiyaT. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem. 1996; 98: 195\u2013201.","DOI":"10.1016\/S0065-1281(96)80038-9"},{"key":"bib10","doi-asserted-by":"crossref","unstructured":"Kria\n              L\n             OhiraA AmemiyaT. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998; 236: 702\u2013708.","DOI":"10.1007\/s004170050144"},{"key":"bib11","doi-asserted-by":"crossref","unstructured":"Jester\n              JV\n             Barry-LanePA CavanaghHD PetrollWM. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996; 15: 505\u2013516.","DOI":"10.1097\/00003226-199609000-00011"},{"key":"bib12","doi-asserted-by":"crossref","unstructured":"Jester\n              JV\n             Barry-LanePA PetrollWM OlsenDR CavanaghHD. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea. 1997; 16: 177\u2013187.","DOI":"10.1097\/00003226-199703000-00010"},{"key":"bib13","doi-asserted-by":"crossref","unstructured":"Jeon\n              K-I\n             KulkarniA WoellerCFet al.\n\n          Inhibitory effects of PPAR? ligands on TGF-\u00df1\u2013induced corneal myofibroblast transformation. Am J Pathol. 2014; 184: 1429\u20131445.","DOI":"10.1016\/j.ajpath.2014.01.026"},{"key":"bib14","doi-asserted-by":"crossref","unstructured":"Gui\n              YS\n             WangL TianXet al.\n\n          mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis. PLoS One. 2015; 10: e0138625.","DOI":"10.1371\/journal.pone.0138625"},{"key":"bib15","doi-asserted-by":"crossref","unstructured":"Milani\n              BY\n             MilaniFY ParkDWet al.\n\n          Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2013; 54: 7424\u20137430.","DOI":"10.1167\/iovs.13-12674"},{"key":"bib16","doi-asserted-by":"crossref","unstructured":"Cho HJ Baek KE Saika S Jeong MJ Yoo J. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase\/Akt signal pathway. Biochem Biophys Res Commun. 2007; 353: 337\u2013343.","DOI":"10.1016\/j.bbrc.2006.12.035"},{"key":"bib17","unstructured":"Dobashi Y Watanabe Y Miwa C Suzuki S Koyama S. Mammalian target of rapamycin: a central node of complex signaling cascades. Int J Clin Exp Pathol. 2011; 4: 476\u2013495."},{"key":"bib18","doi-asserted-by":"crossref","unstructured":"Driscoll DR Karim SA Sano Met al.\n\n          mTORC2 signaling drives the development and progression of pancreatic cancer. Cancer Res. 2016; 76: 6911\u20136923.","DOI":"10.1158\/0008-5472.CAN-16-0810"},{"key":"bib19","doi-asserted-by":"crossref","unstructured":"Hay N Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004; 18: 1926\u20131945.","DOI":"10.1101\/gad.1212704"},{"key":"bib20","doi-asserted-by":"crossref","unstructured":"Huang K Fingar DC. Growing knowledge of the mTOR signaling network. Semin Cell Dev Biol. 2014; 36: 79\u201390.","DOI":"10.1016\/j.semcdb.2014.09.011"},{"key":"bib21","doi-asserted-by":"crossref","unstructured":"Chiarini F Evangelisti C McCubrey JA Martelli AM. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci. 2015; 36: 124\u2013135.","DOI":"10.1016\/j.tips.2014.11.004"},{"key":"bib22","doi-asserted-by":"crossref","unstructured":"Park S Sim H Lee K. Rapamycin-resistant and torin-sensitive mTOR signaling promotes the survival and proliferation of leukemic cells. BMB Rep. 2016; 49: 63\u201368.","DOI":"10.5483\/BMBRep.2016.49.1.201"},{"key":"bib23","doi-asserted-by":"crossref","unstructured":"Liang CC Park AY Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007; 2: 329\u2013333.","DOI":"10.1038\/nprot.2007.30"},{"key":"bib24","doi-asserted-by":"crossref","unstructured":"Montesano R Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA. 1988; 85: 4894\u20134897.","DOI":"10.1073\/pnas.85.13.4894"},{"key":"bib25","doi-asserted-by":"crossref","unstructured":"Hu B Phan SH. Myofibroblasts. Curr Opin Rheumatol. 2013; 25: 71\u201377.","DOI":"10.1097\/BOR.0b013e32835b1352"},{"key":"bib26","doi-asserted-by":"crossref","unstructured":"Yang X Chen B Liu T Chen X. Reversal of myofibroblast differentiation: a review. Eur J Pharmacol. 2014; 734: 83\u201390.","DOI":"10.1016\/j.ejphar.2014.04.007"},{"key":"bib27","doi-asserted-by":"crossref","unstructured":"Saxton RA Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017; 168: 960\u2013976.","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"bib28","doi-asserted-by":"crossref","unstructured":"Kim KW Park SH Lee SH Kim JC. Upregulated stromal cell-derived factor 1 (SDF-1) expression and its interaction with CXCR4 contribute to the pathogenesis of severe pterygia. Invest Ophthalmol Vis Sci. 2013; 54: 7198\u2013206.","DOI":"10.1167\/iovs.13-13044"},{"key":"bib29","doi-asserted-by":"crossref","unstructured":"Hinz B Phan SH Thannickal VJ Galli A Bochaton-Piallat ML Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170: 1807\u20131816.","DOI":"10.2353\/ajpath.2007.070112"},{"key":"bib30","doi-asserted-by":"crossref","unstructured":"Tomasek JJ Gabbiani G Hinz B Chaponnier C Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3: 349\u2013363.","DOI":"10.1038\/nrm809"},{"key":"bib31","doi-asserted-by":"crossref","unstructured":"Van De Water L Varney S Tomasek JJ. Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention. Adv Wound Care (New Rochelle). 2013; 2: 122\u2013141.","DOI":"10.1089\/wound.2012.0393"},{"key":"bib32","doi-asserted-by":"crossref","unstructured":"Cybulski N Hall MN. TOR complex 2: a signaling pathway of its own. Trends Biochem Sci. 2009; 34: 620\u2013627.","DOI":"10.1016\/j.tibs.2009.09.004"},{"key":"bib33","doi-asserted-by":"crossref","unstructured":"Goncharova EA Goncharov DA Li Het al.\n\n          mTORC2 is required for proliferation and survival of TSC2-null cells. Mol Cell Biol. 2011; 31: 2484\u20132498.","DOI":"10.1128\/MCB.01061-10"},{"key":"bib34","doi-asserted-by":"crossref","unstructured":"Facchinetti V Ouyang W Wei Het al.\n\n          The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 2008; 27: 1932\u20131943.","DOI":"10.1038\/emboj.2008.120"},{"key":"bib35","doi-asserted-by":"crossref","unstructured":"Mesquita RF Paul MA Valmaseda Aet al.\n\n          Protein kinase cepsilon-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts. Mol Cell Biol. 2014; 34: 574\u2013594.","DOI":"10.1128\/MCB.01098-13"},{"key":"bib36","doi-asserted-by":"crossref","unstructured":"Bogatkevich GS Tourkina E Silver RM Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem. 2001; 276: 45184\u201345192.","DOI":"10.1074\/jbc.M106441200"},{"key":"bib37","doi-asserted-by":"crossref","unstructured":"Zhou HY Chen WD Zhu DLet al.\n\n          The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts. J Vasc Res. 2010; 47: 9\u201315.","DOI":"10.1159\/000231716"},{"key":"bib38","doi-asserted-by":"crossref","unstructured":"Lee K Gudapati P Dragovic Set al.\n\n          Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity. 2010; 32: 743\u2013753.","DOI":"10.1016\/j.immuni.2010.06.002"},{"key":"bib39","doi-asserted-by":"crossref","unstructured":"Zoncu R Efeyan A Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12: 21\u201335.","DOI":"10.1038\/nrm3025"},{"key":"bib40","doi-asserted-by":"crossref","unstructured":"Wang S Wilkes MC Leof EB Hirschberg R. Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis. Am J Physiol Renal Physiol. 2010; 298: F142\u2013F149.","DOI":"10.1152\/ajprenal.00320.2009"},{"key":"bib41","doi-asserted-by":"crossref","unstructured":"Zhao XR Zhang MC Xie HT Ji N Ma XQ. Expression of mTOR in primary pterygium and its correlation with alpha-smooth muscle actin. Eur J Ophthalmol. 2017:\n27: 664\u2013669.","DOI":"10.5301\/ejo.5000985"},{"key":"bib42","doi-asserted-by":"crossref","unstructured":"Renken C Fischer DC Kundt G Gretz N Haffner D. Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol Dial Transplant. 2011; 26: 92\u2013100.","DOI":"10.1093\/ndt\/gfq384"},{"key":"bib43","unstructured":"Barbari A Maawad M Kfoury Kassouf H Kamel G. Mammalian target of rapamycin inhibitors and nephrotoxicity: fact or fiction. Exp Clin Transplant. 2015; 13: 377\u2013386."},{"key":"bib44","doi-asserted-by":"crossref","unstructured":"Choo AY Yoon SO Kim SG Roux PP Blenis J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA. 2008; 105: 17414\u201317419.","DOI":"10.1073\/pnas.0809136105"},{"key":"bib45","doi-asserted-by":"crossref","unstructured":"Rozengurt E Soares HP Sinnet-Smith J. Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther. 2014; 13: 2477\u20132488.","DOI":"10.1158\/1535-7163.MCT-14-0330"},{"key":"bib46","doi-asserted-by":"crossref","unstructured":"Xie J Wang X Proud CG. mTOR inhibitors in cancer therapy. F1000Res. 2016; 5.","DOI":"10.12688\/f1000research.9207.1"},{"key":"bib47","doi-asserted-by":"crossref","unstructured":"Kim YC Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015; 125: 25\u201332.","DOI":"10.1172\/JCI73939"},{"key":"bib48","doi-asserted-by":"crossref","unstructured":"Kim SW Park S Im CY Seo KY Kim EK. Prediction of mean corneal power change after pterygium excision. Cornea. 2014; 33: 148\u2013153.","DOI":"10.1097\/ICO.0000000000000036"},{"key":"bib49","doi-asserted-by":"crossref","unstructured":"Li G Li YY Sun JE Lin WH Zhou RX. ILK-PI3K\/AKT pathway participates in cutaneous wound contraction by regulating fibroblast migration and differentiation to myofibroblast. Lab Invest. 2016; 96: 741\u2013751.","DOI":"10.1038\/labinvest.2016.48"},{"key":"bib50","doi-asserted-by":"crossref","unstructured":"Abdalla M Goc A Segar L Somanath PR. Akt1 mediates alpha-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor. J Biol Chem. 2013; 288: 33483\u201333493.","DOI":"10.1074\/jbc.M113.504290"},{"key":"bib51","doi-asserted-by":"crossref","unstructured":"Abdalla M Sabbineni H Prakash R Ergul A Fagan SC Somanath PR. The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFbeta-induced pulmonary fibrosis. Br J Pharmacol. 2015; 172: 4173\u20134188.","DOI":"10.1111\/bph.13203"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2720408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:12Z","timestamp":1791927072000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2720408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-25376","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,14]]}}}